Ultragenyx Pharmaceutical reported $227.36M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Aptinyx Inc APTX:US USD 2.69M 2.99M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Insmed INSM:US USD 137.65M 23.84M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Kyowa Hakko Kirin 4151:JP JPY 104.75B 1.25B
Macrogenics MGNX:US USD 50.05M 831K
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Moderna Inc MRNA:US USD 6.81B 5M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Puma Biotechnology PBYI:US USD 59.99M 3.15M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
Vital Therapies VTL:US USD 11.51M 1.11M
Xoma XOMA:US USD 5.42M 3M